Cita APA (7th ed.)

Latini, R., Staszewsky, L., Sun, J., Bethel, M., Disertori, M., Haffner, S., . . . McMurray, J. (2013). Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Cita Chicago (17th ed.)

Latini, R., et al. Incidence of Atrial Fibrillation in a Population with Impaired Glucose Tolerance: The Contribution of Glucose Metabolism and Other Risk Factors. A Post Hoc Analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial. 2013.

Cita MLA (9th ed.)

Latini, R., et al. Incidence of Atrial Fibrillation in a Population with Impaired Glucose Tolerance: The Contribution of Glucose Metabolism and Other Risk Factors. A Post Hoc Analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial. 2013.

Atenció: Aquestes cites poden no estar 100% correctes.